Coprobate en es it fr

Coprobate Brand names, Coprobate Analogs

Coprobate Brand Names Mixture

  • No information avaliable

Coprobate Chemical_Formula


Coprobate RX_link

Coprobate fda sheet

Coprobate msds (material safety sheet)

Coprobate Synthesis Reference

Berger, Ludwig, U.S. Pat. 2,937,119 (1960)

Coprobate Molecular Weight

260.33 g/mol

Coprobate Melting Point

92-93 oC

Coprobate H2O Solubility

0.3 mg/ml

Coprobate State


Coprobate LogP


Coprobate Dosage Forms


Coprobate Indication

For the relief of discomfort associated with acute, painful, musculoskeletal conditions.

Coprobate Pharmacology

Carisoprodol is used as a skeletal muscle relaxant. One of its metabolites, meprobamate, is available as an anxiolytic agent.

Coprobate Absorption

No information avaliable

Coprobate side effects and Toxicity

Symptoms of overdose include drowsiness, giddiness, nausea, indigestion, or rash. Other adverse effects attributed to therapeutic use of carisoprodol include dizziness, irritability, insomnia, diplopia, temporary loss of vision, ataxia, weakness, headache, and dysarthria. Non-CNS adverse effects include gastrointestinal complaints, tachycardia, and postural hypotension. Patients sensitive to sulfites or tartrazine may experience wheezing, allergic rashes including erythema multiforme, or anaphylaxis after using some preparations of carisoprodol which contain such additives

Coprobate Patient Information

Carisoprodol is a muscle relaxant used to relieve the pain and stiffness of muscle spasms and discomfort due to strain and sprain. Inform your physician if you are pregnant or nursing. Do not take this medication with a monoamine oxidase inhibitor. This medication may cause dizziness, drowsiness, or blurred vision; use caution while driving or operating hazardous machinery. Do not take any other sedating drugs or drink alcohol while taking carisoprodol. If dizziness occurs, avoid sudden changes in posture. Take this medication with food to avoid stomach upset. Notify your physician if you develop trouble breathing, unexplained fever, severe weakness, vision changes, swelling, or skin rash. Withdrawal symptoms may occur if therapy is suddenly stopped in a patient on long-term or high-dose therapy.

Coprobate Organisms Affected

Humans and other mammals